Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of extramural DAIT/NIAID pharmacy programs, research pharmacist scientist oversight on study performance, and lessons learned

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106938Source: DataRank Database

Impact of extramural DAIT/NIAID pharmacy programs, research pharmacist scientist oversight on study performance, and lessons learned is a research paper published in Contemporary Clinical Trials (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: greenTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Shannon Gallagher ORCID,Ana M. Ortega‐Villa ORCID,Lisa M. Wheatley,Ousmane Touré ORCID,Sanaz Daneshfar Hamrah

Live enrichment

PubMed:36174959 OpenAlex:https://openalex.org/W4297140986

U.S. Department of Health and Human Services

Grant: 5UM2AI117870

U.S. Department of Health and Human Services

Grant: 75N93019C00003

U.S. Department of Health and Human Services

Grant: HHSN272201200004C

NIAID NIH HHS

Grant: UM2 AI117870

Intramural NIH HHS

Grant: Z99 AI999999

FWCI

0.00

Citation Percentile

0.1%

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9839469

publisherhttps://api.elsevier.com/content/article/PII:S1551714422002646?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1551714422002646?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cct.2022.106938

Fields of Study

Pharmaceutical industry and healthcareStatistical Methods in Clinical TrialsBiosimilars and Bioanalytical MethodsUnited StatesHumansNational Institute of Allergy and Infectious Diseases (U.S.)Pharmaceutical ServicesPharmacistsRetrospective StudiesPharmacy

MeSH Terms

HumansPharmaceutical ServicesPharmacistsPharmacyRetrospective StudiesUnited StatesNational Institute of Allergy and Infectious Diseases (U.S.)

Keywords

PharmacistMedicinePharmacyClinical pharmacyClinical trialFamily medicineObservational studyInternal medicineClinical trial performancePharmacy programProtocol deviationsResearch pharmacistSponsor oversightStudy management